CDK2 and neuroblastoma: Controversially, tumour suppressive role has been suggested for miR-885-5p in neuroblastoma, where it interferes with cell proliferation and survival through cyclin-dependent kinase (CDK2), minichromosome maintenance protein (MCM5) and p53 [27].